-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Zentalis Pharmaceuticals, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2019 to Q3 2024.
- Zentalis Pharmaceuticals, Inc. Depreciation, Depletion and Amortization for the quarter ending September 30, 2024 was $321K, a 7.76% decline year-over-year.
- Zentalis Pharmaceuticals, Inc. Depreciation, Depletion and Amortization for the twelve months ending September 30, 2024 was $1.31M, a 7.23% decline year-over-year.
- Zentalis Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2023 was $1.39M, a 2.6% decline from 2022.
- Zentalis Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2022 was $1.43M, a 162% increase from 2021.
- Zentalis Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2021 was $544K, a 240% increase from 2020.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)